Careers Media center Contacts
LINCOMYCIN
LINCOMYCIN

lincomycin | J01F F02

Capsules

Infections due to microorganisms susceptible to the drug: infections of bones and joints (osteomyelitis, septic arthritis); infections of ENT organs and respiratory tract, otitis, sinusitis, acute bronchitis, pneumonia; purulent skin and soft tissue infections (furunculosis, abscess, infected wound, panaritium, mastitis), erysipelatous inflammation.

LINEZOLIDIN
LINEZOLIDIN

linezolid | J01Х Х08

Solution for injection

Treatment of infections caused by susceptible strains of aerobic and anaerobic gram-positive bacteria, including infections, accompanied by bacteremia, such as: nosocomial pneumonia; community acquired pneumonia; complicated infections of the skin and its structures, particularly infections secondary to the diabetic foot without concomitant osteomyelitis, caused by Staphylococcus aureus (methicillin-sensitive and methicillin-resistant isolates), Streptococcus pyogenes, or Streptococcus agalactiae; uncomplicated infections of the skin and its structures caused by Staphylococcus aureus (methicillin-sensitive isolates only) or Streptococcus pyogenes; infections caused by enterococci, including vancomycin-resistant strains of Enterococcus faecium and faecalis. If infection pathogens include gram-negative bacteria, combination therapy is clinically indicated.

LINEZOLIDIN
LINEZOLIDIN

linezolid | J01X X08

Tablets

Treatment of infections caused by susceptible strains of aerobic and anaerobic gram-positive bacteria, including infections, accompanied by bacteremia, such as: nosocomial pneumonia; community acquired pneumonia; complicated infections of the skin and its structures, particularly infections secondary to the diabetic foot without concomitant osteomyelitis, caused by Staphylococcus aureus (methicillin-sensitive and methicillin-resistant isolates), Streptococcus pyogenes, or Streptococcus agalactiae; uncomplicated infections of the skin and its structures caused by Staphylococcus aureus (methicillin-sensitive isolates only) or Streptococcus pyogenes; infections caused by enterococci, including vancomycin-resistant strains of Enterococcus faecium and faecalis. If infection pathogens include gram-negative bacteria, combination therapy is clinically indicated.

LOPERAMIDE
LOPERAMIDE

loperamide | A07DA03

Tablets

Symptomatic treatment for acute and chronic diarrhea of various geneses; non-septic form of irritable bowel syndrome; after ileostomy (to reduce the frequency and volume of stools and to solidify its consistency).

LORATADINE
LORATADINE

loratadine | R06AX13

Tablets

Seasonal (pollinosis) and perennial allergic rhinitis and allergic conjunctivitis – for relief of symptoms associated with these diseases: sneezing, nasal itching, rhinorrhea; itching and burning sensation in the eyes, tearing. Chronic idiopathic urticaria. Allergic skin diseases.

LORIZAN
LORIZAN

loratadine | R06AX13

Tablets

Allergic rhinitis (seasonal and perennial), allergic conjunctivitis and relief of symptoms associated with this disease (watery eyes, rhinorrhea, sneezing, nose itching, inflammation and itching of the conjunctiva), chronic idiopathic urticaria, allergic skin diseases.


The presented package image matches the product design registered with the Ukrainian regulatory authorities.

If you have noticed any differences, please call us at +380 44 490 75 22

PHARMACOVIGILANCE

If you have information about any adverse effects or other drug-related problems, please fill in the form